Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2O.Ti |
| Molecular Weight | 79.866 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[O--].[O--].[Ti+4]
InChI
InChIKey=SOQBVABWOPYFQZ-UHFFFAOYSA-N
InChI=1S/2O.Ti/q2*-2;+4
| Molecular Formula | O |
| Molecular Weight | 15.9994 |
| Charge | -2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Ti |
| Molecular Weight | 47.867 |
| Charge | 4 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022009s000_ClinPharmR.pdf | https://www.ncbi.nlm.nih.gov/pubmed/18503414
Curator's Comment: description was created based on several sources, including
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022009s000_ClinPharmR.pdf | https://www.ncbi.nlm.nih.gov/pubmed/18503414
Titanium dioxide, also known as titanium(IV) oxide or titania, is the naturally occurring oxide of titanium, chemical formula TiO
2. When used as a pigment, it is called titanium white, Pigment White 6 (PW6), or CI 77891. Generally it is sourced from ilmenite, rutile and anatase. It has a wide range of applications, from paint to sunscreen to food coloring. When used as a food coloring, it has E number E171. World production in 2014 exceeded 9 million metric tons. Titanium dioxide has excellent ultraviolet (UV) resistant qualities and acts as a UV absorbent. In the pharmaceutical industry, titanium dioxide is used in most sunscreens to block UVA and UVB rays, similar to zinc oxide. It is also commonly used as pigment for pharmaceutical products such as gelatin capsules, tablet coatings and syrups. In the cosmetics industry, it is used in toothpaste, lipsticks, creams, ointments and powders. It can be used as an opacifier to make pigments opaque. The FDA has approved the safety of titanium dioxide for use as a colorant in food, drugs and cosmetics, including sunscreens. However, controversy exists as to the safety of titanium dioxide nanoparticles used in the cosmetics industry, for example in sunscreens. Titanium and zinc oxides may be made into the nanoparticle size (0.2-100 nanometers) to reduce the white appearance when applied topically, but retain the UV blocking properties. Recent studies suggest titanium dioxide nanoparticles may be toxic, although further research is needed.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Increased expression of manganese-containing superoxide dismutase in rat lungs after inhalation of inflammatory and fibrogenic minerals. | 1994 Mar |
|
| Activation of human neutrophils by titanium dioxide (TiO2) nanoparticles. | 2010 Apr |
|
| Involvement of JNK and P53 activation in G2/M cell cycle arrest and apoptosis induced by titanium dioxide nanoparticles in neuron cells. | 2010 Dec 15 |
|
| Airway exposure to silica-coated TiO2 nanoparticles induces pulmonary neutrophilia in mice. | 2010 Feb |
|
| Engineered nanomaterials cause cytotoxicity and activation on mouse antigen presenting cells. | 2010 Jan 12 |
|
| Titanium dioxide nanoparticles cause apoptosis in BEAS-2B cells through the caspase 8/t-Bid-independent mitochondrial pathway. | 2010 Jun 16 |
|
| Spleen injury and apoptotic pathway in mice caused by titanium dioxide nanoparticules. | 2010 Jun 2 |
|
| Cellular responses by stable and uniform ultrafine titanium dioxide particles in culture-medium dispersions when secondary particle size was 100 nm or less. | 2010 Sep |
|
| The effect of TiO(2) and Ag nanoparticles on reproduction and development of Drosophila melanogaster and CD-1 mice. | 2011 Dec 15 |
|
| Chemoprotective effect of N-acetylcysteine (NAC) on cellular oxidative damages and apoptosis induced by nano titanium dioxide under UVA irradiation. | 2011 Feb |
|
| Acute respiratory and systemic toxicity of pulmonary exposure to rutile Fe-doped TiO(2) nanorods. | 2011 Jan 11 |
|
| Pulmonary response to surface-coated nanotitanium dioxide particles includes induction of acute phase response genes, inflammatory cascades, and changes in microRNAs: a toxicogenomic study. | 2011 Jul |
|
| Cellular oxidative damage of HEK293T cells induced by combination of CdCl(2) and nano-TiO (2). | 2011 Jun |
|
| Particle stimulation dephosphorylates glutathione S-transferase π1 of epithelial cells. | 2011 Jun 18 |
|
| Titanium oxide shell coatings decrease the cytotoxicity of ZnO nanoparticles. | 2011 Mar 21 |
|
| Safety evaluation of sunscreen formulations containing titanium dioxide and zinc oxide nanoparticles in UVB sunburned skin: an in vitro and in vivo study. | 2011 Sep |
|
| Gene expression of zebrafish embryos exposed to titanium dioxide nanoparticles and hydroxylated fullerenes. | 2011 Sep |
|
| DNA damage and alterations in expression of DNA damage responsive genes induced by TiO2 nanoparticles in human hepatoma HepG2 cells. | 2011 Sep |
|
| Molecular control of TiO₂-NPs toxicity formation at predicted environmental relevant concentrations by Mn-SODs proteins. | 2012 |
|
| TiO₂ nanoparticles induce dysfunction and activation of human endothelial cells. | 2012 Apr 16 |
|
| Ovarian dysfunction and gene-expressed characteristics of female mice caused by long-term exposure to titanium dioxide nanoparticles. | 2012 Dec |
|
| Titanium dioxide nanoparticles inhibit proliferation and induce morphological changes and apoptosis in glial cells. | 2012 Dec 16 |
|
| Titanium dioxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in human amnion epithelial (WISH) cells. | 2012 Mar |
|
| Distinct immunomodulatory effects of a panel of nanomaterials in human dermal fibroblasts. | 2012 May 5 |
|
| Four types of inorganic nanoparticles stimulate the inflammatory reaction in brain microglia and damage neurons in vitro. | 2012 Oct 17 |
|
| Nanosized TiO2-induced reproductive system dysfunction and its mechanism in female mice. | 2013 |
|
| Molecular mechanisms of nanosized titanium dioxide-induced pulmonary injury in mice. | 2013 |
|
| Titanium dioxide nanoparticles increase inflammatory responses in vascular endothelial cells. | 2013 Apr 5 |
|
| Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549. | 2013 Feb |
|
| Differential mouse pulmonary dose and time course responses to titanium dioxide nanospheres and nanobelts. | 2013 Jan |
|
| TiO2, CeO2 and ZnO nanoparticles and modulation of the degranulation process in human neutrophils. | 2013 Jul 31 |
|
| Pulmonary instillation of low doses of titanium dioxide nanoparticles in mice leads to particle retention and gene expression changes in the absence of inflammation. | 2013 Jun 15 |
|
| Improving cytocompatibility of Co28Cr6Mo by TiO2 coating: gene expression study in human endothelial cells. | 2013 Sep 6 |
|
| Effect of TiO₂ nanoparticles on the structure and activity of catalase. | 2014 Aug 5 |
|
| Genetic variation influences immune responses in sensitive rats following exposure to TiO2 nanoparticles. | 2014 Dec 4 |
|
| Titanium dioxide nanoparticles promote arrhythmias via a direct interaction with rat cardiac tissue. | 2014 Dec 9 |
|
| Genotoxicity of silver and titanium dioxide nanoparticles in bone marrow cells of rats in vivo. | 2014 Jan 6 |
|
| Zinc oxide nanoparticles induce migration and adhesion of monocytes to endothelial cells and accelerate foam cell formation. | 2014 Jul 1 |
|
| Effect of pubertal nano-TiO2 exposure on testosterone synthesis and spermatogenesis in mice. | 2014 Mar |
|
| Normalization of nano-sized TiO2-induced clastogenicity, genotoxicity and mutagenicity by chlorophyllin administration in mice brain, liver, and bone marrow cells. | 2014 Nov |
|
| Sheet-type titania, but not P25, induced paraptosis accompanying apoptosis in murine alveolar macrophage cells. | 2014 Oct 1 |
|
| Effect of glycyrrhizic acid on titanium dioxide nanoparticles-induced hepatotoxicity in rats. | 2014 Sep 5 |
|
| Effects of titanium dioxide nanoparticles on lead bioconcentration and toxicity on thyroid endocrine system and neuronal development in zebrafish larvae. | 2015 Apr |
|
| Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells. | 2015 Apr |
|
| Genome wide identification and expression profile in epithelial cells exposed to TiO₂ particles. | 2015 Mar |
|
| Titanium nanoparticle inhalation induces renal fibrosis in mice via an oxidative stress upregulated transforming growth factor-β pathway. | 2015 Mar 16 |
|
| Silver and titanium dioxide nanoparticles alter oxidative/inflammatory response and renin-angiotensin system in brain. | 2015 Nov |
|
| Cyto- and genotoxic effects of metallic nanoparticles in untransformed human fibroblast. | 2015 Oct |
|
| Titanium dioxide nanoparticles modulate the toxicological response to cadmium in the gills of Mytilus galloprovincialis. | 2015 Oct 30 |
|
| TiO2 nanoparticle-induced neurotoxicity may be involved in dysfunction of glutamate metabolism and its receptor expression in mice. | 2016 Jun |
Sample Use Guides
Apply evenly 15 minutes before sun exposure. Reapply as needed or after towel drying, swimming, or perspiring. Children under 6 months of age, ask a doctor.
Route of Administration:
Topical
For the in vitro studies, the stratum corneum side of the skin was in contact with either the aqueous or oily commercial dispersion of microfine TiO2 (150 μl/cm^2). The dermis side was placed onto a tissue of cellulose soaked with isotonic phosphate buffered saline (PBS) of pH 7.4. Twenty-four hours after application of the dispersion, the PBS was removed from the skin with a dry paper towel. For the in vivo studies, 2 μl cm−2 of the commercial dispersions and the different formulations were applied onto the ventral side of the forearm of a healthy female volunteer. After 45 min, any dispersion or formulation that had not penetrated the skin was also removed with a paper towel. All penetration tests were performed in triplicate.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:38:43 GMT 2023
by
admin
on
Fri Dec 15 15:38:43 GMT 2023
|
| Record UNII |
15FIX9V2JP
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CODEX ALIMENTARIUS (GSFA) |
INS-171
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
||
|
CFR |
21 CFR 178.3297
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
||
|
NCI_THESAURUS |
C461
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
||
|
DSLD |
1166 (Number of products:1)
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 38
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
||
|
FDA ORPHAN DRUG |
199204
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 575
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
||
|
JECFA EVALUATION |
INS-171
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
||
|
CFR |
21 CFR 352.20
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
||
|
CFR |
21 CFR 176.170
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
||
|
CFR |
21 CFR 175.210
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/05/262
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
||
|
EPA PESTICIDE CODE |
NOT YET ASSIGNED
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 576
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
||
|
CFR |
21 CFR 352.10
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
||
|
FDA ORPHAN DRUG |
142401
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 577
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB12611MIG
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | |||
|
869
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | |||
|
C61975
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | |||
|
C009495
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | |||
|
DB09536
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | |||
|
DTXSID3021352
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | |||
|
1667585
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | |||
|
4237
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | |||
|
1317-80-2
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
ALTERNATIVE | |||
|
162651
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | |||
|
46748
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | |||
|
13463-67-7
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | |||
|
38323
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | RxNorm | ||
|
15FIX9V2JP
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | |||
|
TITANIUM DIOXIDE
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | |||
|
32234
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | |||
|
134438
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | |||
|
236-675-5
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | |||
|
15FIX9V2JP
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | |||
|
1344-29-2
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
ALTERNATIVE | |||
|
m10898
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000092217
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | |||
|
CHEMBL1201136
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY | |||
|
215-282-2
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
ALTERNATIVE | |||
|
15204
Created by
admin on Fri Dec 15 15:38:43 GMT 2023 , Edited by admin on Fri Dec 15 15:38:43 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
